The endothelin axis: emerging role in cancer

[1]  S. Shibata,et al.  A selective endothelin ETA antagonist, BQ-123, inhibits125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells , 1994, Cellular and Molecular Neurobiology.

[2]  J. Nelson,et al.  Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  F. Balkwill,et al.  Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells. , 2002, Molecular cancer therapeutics.

[4]  N. Perico,et al.  New therapeutics that antagonize endothelin: promises and frustrations , 2002, Nature Reviews Drug Discovery.

[5]  P. Natali,et al.  Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade. , 2002, Cancer research.

[6]  F. Spinella,et al.  ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro. , 2002, Clinical science.

[7]  F. Spinella,et al.  Endothelin-1 promotes proteolytic activity of ovarian carcinoma. , 2002, Clinical science.

[8]  F. Spinella,et al.  Endothelin-1 Induces Vascular Endothelial Growth Factor by Increasing Hypoxia-inducible Factor-1α in Ovarian Carcinoma Cells* , 2002, The Journal of Biological Chemistry.

[9]  G. Mundy Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[10]  J. Nelson,et al.  Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Jeroen van derBoon New drug slows prostate-cancer progression. , 2002 .

[12]  F. Spinella,et al.  Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation. , 2002, Molecular pharmacology.

[13]  J. van der Boon New drug slows prostate-cancer progression. , 2002, The Lancet. Oncology.

[14]  F. Spinella,et al.  Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. , 2001, Cancer research.

[15]  G. Burnstock,et al.  Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET A receptor antagonism , 2001, British Journal of Cancer.

[16]  G. Filippatos,et al.  Regulation of apoptosis by vasoactive peptides. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[17]  S. Kitazawa,et al.  Expression of endothelin receptor a associated with prostate cancer progression. , 2001, The Journal of urology.

[18]  A. Albini,et al.  Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells. , 2001, The American journal of pathology.

[19]  F. Pinet,et al.  Modulation of human colon tumor-stromal interactions by the endothelin system. , 2000, The American journal of pathology.

[20]  T. Lüscher,et al.  Endothelins and Endothelin Receptor Antagonists: Therapeutic Considerations for a Novel Class of Cardiovascular Drugs , 2000, Circulation.

[21]  P. Natali,et al.  Role of endothelin-1 in neovascularization of ovarian carcinoma. , 2000, The American journal of pathology.

[22]  F. Pinet,et al.  Endothelin receptor blockade potentiates FasL-induced apoptosis in colon carcinoma cells via the protein kinase C-pathway. , 2000, Journal of cardiovascular pharmacology.

[23]  G. Taraboletti,et al.  Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. , 2000, The American journal of pathology.

[24]  A. Venuti,et al.  Expression of endothelin 1 and endothelin A receptor in HPV‐associated cervical carcinoma: new potential targets for anticancer therapy , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  K. Catt,et al.  Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells. , 2000, Cancer research.

[26]  Y. M. Yang,et al.  Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption , 2000, British Journal of Cancer.

[27]  J. Nelson,et al.  Endothelium‐derived factors as paracrine mediators of prostate cancer progression , 2000, The Prostate.

[28]  T. Guise Molecular mechanisms of osteolytic bone metastases , 2000, Cancer.

[29]  J. R. Wu-wong,et al.  Extracellular signal-regulated kinases are involved in the antiapoptotic effect of endothelin-1. , 2000, The Journal of pharmacology and experimental therapeutics.

[30]  L. Juillerat-Jeanneret,et al.  Endothelin receptor blockade potentiates FasL‐induced apoptosis in rat colon carcinoma cells , 2000, International journal of cancer.

[31]  P. Woll,et al.  Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. , 2000, American journal of respiratory cell and molecular biology.

[32]  Chakrabarti,et al.  Augmented expression of endothelin‐1, endothelin‐3 and the endothelin‐B receptor in breast carcinoma , 2000, Histopathology.

[33]  M. Clozel Endothelin receptor antagonists: current status and perspectives. , 2000, Journal of cardiovascular pharmacology.

[34]  M. Mcmillen,et al.  Endothelins are angiogenic. , 2000, Journal of cardiovascular pharmacology.

[35]  T. Masaki The endothelin family: an overview. , 2000, Journal of cardiovascular pharmacology.

[36]  E. Fearon,et al.  Cancer progression , 1999, Current Biology.

[37]  P. Patterson,et al.  An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Smyth,et al.  Paracrine regulation of ovarian cancer by endothelin. , 1999, European journal of cancer.

[39]  T. Yoneda,et al.  Factors regulating the growth of metastatic cancer in bone. , 1999, Endocrine-related cancer.

[40]  J. Eberle,et al.  Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes. , 1999, The Journal of investigative dermatology.

[41]  J. Nelson,et al.  The Role of the Endothelin Axis in Prostate Cancer , 1999 .

[42]  J. Nelson,et al.  New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade. , 1999, Urology.

[43]  J. Nelson,et al.  ENDOTHELIN AXIS EXPRESSION IN RENAL CELL CARCINOMA , 1999 .

[44]  R. Goldie ENDOTHELINS IN HEALTH AND DISEASE: AN OVERVIEW , 1999, Clinical and experimental pharmacology & physiology.

[45]  P. Natali,et al.  Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. , 1999, Cancer research.

[46]  K. Catt,et al.  Endothelins as Autocrine Regulators of Tumor Cell Growth , 1998, Trends in Endocrinology & Metabolism.

[47]  J. Pickard,et al.  Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707. , 1998, Neurosurgery.

[48]  H. Krum,et al.  The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. , 1998, The New England journal of medicine.

[49]  H. Lepor,et al.  Endothelin‐1 production and agonist activities in cultured prostate‐derived cells: Implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia , 1998, The Prostate.

[50]  Catherine Magill,et al.  Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression , 1998, Nature Medicine.

[51]  J. R. Wu-wong,et al.  Endothelin attenuates apoptosis in human smooth muscle cells. , 1997, The Biochemical journal.

[52]  M. Shichiri,et al.  Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. , 1997, Hypertension.

[53]  S. Langdon,et al.  Endothelin expression and responsiveness in human ovarian carcinoma cell lines. , 1997, European journal of cancer.

[54]  J. Brooks,et al.  Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate cancer. , 1997, Cancer research.

[55]  M. Mihm,et al.  Decreased ET(B) receptor expression in human metastatic melanoma cells. , 1996, Biochemical and biophysical research communications.

[56]  S. Magnuson,et al.  Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. , 1996, Cancer research.

[57]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[58]  M. Mattei,et al.  Organization of the Gene Encoding the Human Endothelin-converting Enzyme (ECE-1) (*) , 1995, The Journal of Biological Chemistry.

[59]  A. Weindl,et al.  Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth. , 1995, The Journal of clinical investigation.

[60]  K. Catt,et al.  Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[61]  J. Nelson,et al.  Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate , 1995, Nature Medicine.

[62]  H. Wu,et al.  Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down-regulation by 1,25-dihydroxy-vitamin D3. , 1995, Molecular pharmacology.

[63]  E. Levin Mechanisms of disease : endothelins , 1995 .

[64]  T. Opgenorth Endothelin receptor antagonism. , 1995, Advances in pharmacology.

[65]  J. Polak,et al.  Localization and Characterization of Endothelin‐1 Receptor Binding in the Blood Vessels of Human Pulmonary Tumors , 1995, Journal of cardiovascular pharmacology.

[66]  A. Weindl,et al.  Cellular Localization of Endothelin Receptor mRNAs (ETA and ETB) in Brain Tumors and Normal Human Brain , 1995, Journal of cardiovascular pharmacology.

[67]  M. Zamora,et al.  Human melanoma cells express functional endothelin-1 receptors. , 1994, Biochemical and biophysical research communications.

[68]  N. Brière,et al.  Growth regulatory properties of endothelins , 1993, Peptides.

[69]  M. Ogawa,et al.  A large amount of endothelin-1 is present in human breast cancer tissues. , 1991, Research communications in chemical pathology and pharmacology.

[70]  G. Rubanyi,et al.  Endothelins , 1991, The Lancet.

[71]  B. Corrin,et al.  Detection of endothelin immunoreactivity and mRNA in pulmonary tumours , 1990, The Journal of pathology.

[72]  R. Eddy,et al.  Structural organization and chromosomal assignment of the gene encoding endothelin. , 1989, The Journal of biological chemistry.